ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FUM Futura Medical Plc

35.65
0.15 (0.42%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 0.42% 35.65 35.40 35.90 36.50 34.05 36.50 425,707 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.25 106.45M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 35.50p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £106.45 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.25.

Futura Medical Share Discussion Threads

Showing 15526 to 15538 of 21425 messages
Chat Pages: Latest  629  628  627  626  625  624  623  622  621  620  619  618  Older
DateSubjectAuthorDiscuss
21/12/2022
13:38
Next spike up is well overdue ;-)
broomrigg
21/12/2022
13:36
LOLIf you're a fan of PANR as well as this then you're in for a highly "challenging" 2023!Suggest separating yourself from emotions and take a cold hard look at the prospects of a company which must do a large raise early in H1 next year, nevermind the fact the "product" failed its P3.The fact this thread says "FUTURA a winner for 2015" says it all!!!?
truant2tb1
21/12/2022
13:33
Thats how they play

Spread false information and short

j777j
21/12/2022
13:32
"The product doesn't even work for starters!" Well, that makes two people who have claimed that, both of them liars and fantasists, and known stock bashers. Compared to over 60% of men with ED who have tested it in clinical and real world tests and confirmed that it works.
petroc
21/12/2022
13:30
Anyone who calls other people petal,well sums him up





Oh and btw it works great

Consumer In-Use Test

Cooper, as part of its due diligence process, conducted a consumer marketing Home Use Test ("HUT") in the United Kingdom, France and the Netherlands whereby individuals self-diagnosed with ED were provided with a four-pack sample of MED3000. The in-use results were in line with findings published in 2019 in Futura's clinical study FM57 which showed that over two thirds of patients experienced a clinically meaningful benefit from using MED3000 in a controlled clinical setting. MED3000 performed well in the real world, consumer HUT setting, with the majority of men with ED, other than men suffering from severe ED with significant co-morbidities, seeing an improvement in erectile performance and underlining the product's potential as a highly effective, safe, clinically proven, topical treatment for ED.

j777j
21/12/2022
13:22
We genuinely don't. I've read all the information out there and don't believe this company to be worth anything near 52p

The product doesn't even work for starters!

truant2tb1
21/12/2022
12:41
Truant and lbo work together to try spread misinformation and doubt

Sad I know but thats their game


Cant wait to see their faces when the FDA approval comes through

j777j
21/12/2022
12:33
Cat Jeeves whoever that is needs to take some grammar lessons eh?


I just saw this rather more concise article


Futura Medical Price Target 121p



Positive progress continues at Futura Medical, with
MED3000 now under formal review at the FDA and decision
on marketing authorisation expected by the end of Q1
2023. Management continues to set the foundations for the
launch and commercial scale up of MED3000, with
launches in Europe to commence in H1 2023 and in the
Middle East later next year. We believe Eroxon®, the brand
name of MED3000, has the potential to become a global
name as a potential first-in-class OTC treatment for erectile
dysfunction.

We reiterate our BUY and our 121p target
price, and point to the FDA decision and the conclusion of a
US licensing agreement as potential catalysts for further
value creation.





Regulatory progress continues
The FDA has formally accepted the regulatory submission dossier of
MED3000, indicating that it has successfully passed the initial technical
screening setting. This sets in motion a decision on US marketing
authorisation by the end of Q1 2023. This is in line with previously announced
guidelines. We believe that MED3000 has the potential to be a first-in-class
OTC treatment for erectile dysfunction and that the strength of clinical data to
date suggests a high likelihood of approval.



Regulatory progress continues elsewhere and MED3000 has recently received
marketing authorisation in three Middle East countries, including the
significant market of the UAE. Initial launches and further approvals in the
Middle East are expected as we head into 2023. Overall, this highlights that
the building blocks continue to be laid for Eroxon® to become a global brand.
Stage is set for initial launches in 2023



Encouragingly, Futura’s European & UK partner, Cooper Consumer Health,
looks set to commence an initial launch of Eroxon®, the brand name of
MED3000, in H1 2023. In September and in support of a launch, we have
already seen first production orders from Cooper.


More recently, after the
market authorisation of MED3000 in three Middle East nations, Labetec
Pharma, Futura’s distribution partner in the Middle East, has also made first
production orders for a launch planned for 2023. {Liberum)

j777j
21/12/2022
12:06
Just seen an article on Shareprophets - TW's site - on FUM

Look forward to reading!! TW red flagging a company is always a worry

truant2tb1
21/12/2022
10:21
Over 60% of men, WHO HAVE ACTUALLY USED MED3000 IN 2 CLINICAL TRIALS AND A REAL WORLD TEST, confirmed that MED3000 worked for their ED. LiarBO, who has never even seen MED3000, let alone used it, says it doesn't work. Boo hoo!
petroc
21/12/2022
10:18
Luckily, MED3000 had an excellent safety profile with very low incidence of adverse events in males and female partners. Results demonstrated that MED3000 has the potential to be an effective, clinically proven, topical treatment for erectile dysfunction.
petroc
21/12/2022
09:41
The objective data over many years of use. After appropriate assessment and correct use has proven Viagra to be effective and safe. Viagra has a well-established efficacy and tolerability profile. From its introduction in 1998 to 2016, over 64m men worldwide were treated with sildenafil citrate. 'The safety profile of sildenafil citrate is based on over 9,570 patients in 74 double blind placebo-controlled clinical studies as well as postmarketing surveillance that has been gathered over 10 years.' And correlation is not causation.Viagra studies have even showed men taking it live longer.https://www.forbes.com/sites/alexzhavoronkov/2022/06/07/can-viagra-extend-your-life/?sh=614611532c0chttps://www.technologynetworks.com/drug-discovery/news/50-of-trial-subjects-who-took-a-placebo-reported-suffering-an-adverse-event-313037New research has found that half of participants who took a placebo in a clinical trial reported suffering from an adverse event (a side effect of the trial intervention). More surprisingly, 1 in 20 people who were taking placebos dropped out of their trials because of more serious adverse events. The study included data from 1,271 randomized trials and 250,726 trial participants. The adverse events ranged from abdominal pain and anorexia to burning, chest pain, fatigue, and even death
lbo
20/12/2022
22:46
LiarBO seems to base his opposition to MED3000 entirely on a potential placebo effect. Although over 60% of men who have actually used it in clinical trials and a real world test all confirm that it works, LiarBO, who has never seen or used MED3000, claims it doesn't work, and that the results all point to a fantasy placebo response. He then links reams of rubbish about PE in an attempt to 'prove' his assertion.
Unfortunately for LiarBO there is an increasing swell of opinion in medicine to disprove the myth of placebo.

'... A good first step would be to see the placebo response for what it is a conceptual myth that sustains a broken medical system and covers up what we are really seeking our inherit healing capacity now freed by understanding how deeply meaning infuses us all.'

If anyone cares to read about it, try this: target='window'>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707261/

At this point, LiarBO will be sticking his fingers in his ears shouting, 'No, no, no! They're all proven liars!' which he says about everyone who doesn't agree with him.


And another thing - just because something has the potential to cause a placebo response, doesn't mean it does. A bit like just because you're paranoid, it doesn't mean they're NOT out to get you!

'The placebo response is a myth. It does not exist in reality, and continuing to name it is hindering the optimal application of science to healing in medicine. On the surface, it is obvious that, when defined as a biological response to an inert pill (like a sugar pill), the idea of a response to a placebo is impossible. Inert treatments by definition do not produce responses. So why do we continue to ponder why people get better from taking inert substances and base our acceptance of legitimate treatments on demonstrating that they go beyond that response?'

Answer - vested interest. Read the article, all is explained.

petroc
Chat Pages: Latest  629  628  627  626  625  624  623  622  621  620  619  618  Older

Your Recent History

Delayed Upgrade Clock